Last week was International Open Access Week covering the topic ‘Open for whom? Equity in open knowledge’. Open Pharma kicked off this year’s Open Access Week with the launch of its position statement on open access at a MedComms Networking event in Oxford on 21 October 2019. The statement calls for publishers to allow authors … Continue reading Find out what Open Pharma achieved during Open Access Week 2019
Featuring the launch of the Open Pharma position statement on open access, an introduction to the Open Science in Action Inaugural Symposium and a call to action for the UK government to do more to ensure transparent clinical trial reporting.
Featuring researchers’ fears surrounding clinical trial registries, a roundup of the events planned for Open Access Week 2019 and the release of the Open Pharma Charter
Featuring the upcoming MedComms Brunch Meeting on open access, an investigation into the future of open access publishing, news from the third Asia Pacific Meeting of ISMPP and the scientific community’s toxic definition of success
Featuring the Open Pharma and Pint of Science crossover event, a new pilot project to facilitate the transparent review of preprints and the results from a Nature poll on coercive citations
Featuring a novel solution to prevent the spread of disreputable science, top tips on publication planning in small companies and editorial perspectives on the latest Plan S news
Featuring news from Peer Review Week, help for smaller scientific societies with the transition to Plan S and recommendations by NIH to make data more FAIR
Featuring the growing traction of Registered Reports, an investigation into the inconsistent role of a peer reviewer, unusual citation patterns in some manuscripts and a new Plan S toolkit
Featuring the pros and cons of ‘patient-orientated research’, a new addition to the Medical Publishing and Insights Practices (MPIP) open access toolkit and an update on Plan S.
Featuring concerns over financing ‘pay to publish’ models, a fresh demand for clinical trial transparency sanctions, and how one highly cited article may influence a journal’s impact factor and a researcher’s career progression.